|Secukinumab in plaque psoriasis—results of two phase 3 trials|
RG Langley, BE Elewski, M Lebwohl, K Reich, CEM Griffiths, K Papp, ...
New England Journal of Medicine 371 (4), 326-338, 2014
|Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial|
IB McInnes, A Kavanaugh, AB Gottlieb, L Puig, P Rahman, C Ritchlin, ...
The Lancet 382 (9894), 780-789, 2013
|Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions|
BB Davidovici, N Sattar, PC Jörg, L Puig, P Emery, JN Barker, ...
Journal of Investigative Dermatology 130 (7), 1785-1796, 2010
|Phase 3 studies comparing brodalumab with ustekinumab in psoriasis|
M Lebwohl, B Strober, A Menter, K Gordon, J Weglowska, L Puig, K Papp, ...
New England Journal of Medicine 373 (14), 1318-1328, 2015
|Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological …|
C Ritchlin, P Rahman, A Kavanaugh, IB McInnes, L Puig, S Li, Y Wang, ...
Annals of the rheumatic diseases 73 (6), 990-999, 2014
|Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey|
MG Lebwohl, H Bachelez, J Barker, G Girolomoni, A Kavanaugh, ...
Journal of the American Academy of Dermatology 70 (5), 871-881. e30, 2014
|Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of …|
A Kavanaugh, C Ritchlin, P Rahman, L Puig, AB Gottlieb, S Li, Y Wang, ...
Annals of the rheumatic diseases 73 (6), 1000-1006, 2014
|Epidemiology of atopic dermatitis in adults: results from an international survey|
S Barbarot, S Auziere, A Gadkari, G Girolomoni, L Puig, EL Simpson, ...
Allergy 73 (6), 1284-1293, 2018
|Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and …|
KB Gordon, B Strober, M Lebwohl, M Augustin, A Blauvelt, Y Poulin, ...
The Lancet 392 (10148), 650-661, 2018
|Obesity and psoriasis: body weight and body mass index influence the response to biological treatment|
Journal of the European Academy of Dermatology and Venereology 25 (9), 1007-1011, 2011
|Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial|
RG Langley, TF Tsai, S Flavin, M Song, B Randazzo, Y Wasfi, J Jiang, ...
British Journal of Dermatology 178 (1), 114-123, 2018
|Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin|
MT Fernandez‐Figueras, C Carrato, X Sáenz, L Puig, E Musulen, ...
Journal of the European Academy of Dermatology and Venereology 29 (5), 991-997, 2015
|Acute febrile neutrophilic dermatosis (Sweet's syndrome)|
D SITJAS, L PUIG, M CUATRECASAS, JM DE MORAGAS
International journal of dermatology 32 (4), 261-268, 1993
|PASI 90 response: the new standard in therapeutic efficacy for psoriasis|
Journal of the European Academy of Dermatology and Venereology 29 (4), 645-648, 2015
|A consensus report on appropriate treatment optimization and transitioning in the management of moderate‐to‐severe plaque psoriasis|
U Mrowietz, E De Jong, K Kragballe, R Langley, A Nast, L Puig, K Reich, ...
Journal of the European Academy of Dermatology and Venereology 28 (4), 438-453, 2014
|Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis|
E Daudén, S Castañeda, C Suárez, J García‐Campayo, AJ Blasco, ...
Journal of the European Academy of Dermatology and Venereology 27 (11), 1387 …, 2013
|Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and …|
DS Rosenthal, CEM Griffiths, SH Yuspa, DR Roop, JJ Voorhees
Journal of investigative dermatology 98 (3), 1992
|CLINICAL AND LABORATORY INVESTIGATIONS: Pityriasis Lichenoides in Children: Clinicopathologic Review of 22 Patients|
J Romaní, L Puig, MT Fernández‐Figueras, JM de Moragas
Pediatric dermatology 15 (1), 1-6, 1998
|Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III …|
A Kavanaugh, L Puig, AB Gottlieb, C Ritchlin, Y You, S Li, M Song, ...
Annals of the Rheumatic Diseases 75 (11), 1984-1988, 2016
|Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin‐17 inhibitors and their practical management|
DM Saunte, U Mrowietz, L Puig, C Zachariae
British Journal of Dermatology 177 (1), 47-62, 2017